Table 4 The treatment outcomes of different delayed treatment intervals between the hormone group and the uterus-sparing surgery sequential hormone group (surgery group)
Variable | Hormone | Surgery group | χ2 | p | |
|---|---|---|---|---|---|
Total | 672 | 544 | |||
Delayed treatment interval ≦ 12 months | |||||
n | 312 | 230 | |||
Symptoms change, n (%) | 1.819 | 0.177 | |||
Relief | 272 (87.2) | 191 (83.0) | |||
No relief | 40 (12.8) | 39 (17.0) | |||
Hysterectomy, n (%) | 23 (7.4) | 14 (6.1) | 0.344 | 0.558 | |
Delayed treatment interval: 12–24 months | |||||
n | 112 | 72 | |||
Symptoms change, n (%) | 3.340 | 0.068 | |||
Relief | 96 (85.7) | 54 (75.0) | |||
No relief | 16 (14.3) | 18 (25.0) | |||
Hysterectomy, n (%) | 10 (8.9) | 10 (13.9) | 1.113 | 0.291 | |
Delayed treatment interval > 24 months | |||||
n | 251 | 243 | |||
Symptoms change, n (%) | 15.139 | 0.000* | |||
Relief | 135 (54.2) | 173 (71.2) | |||
No relief | 114 (45.8) | 70 (28.8) | |||
Hysterectomy, n (%) | 67 (26.7) | 45 (18.5) | 4.906 | 0.030* | |